Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Genital pain

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44364   clinical trials with a EudraCT protocol, of which   7388   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    27 result(s) found for: Genital pain. Displaying page 1 of 2.
    1  2  Next»
    EudraCT Number: 2019-001572-11 Sponsor Protocol Number: LLB-2019-01 Start Date*: 2020-08-05
    Sponsor Name:LABO’LIFE Belgium sprl
    Full Title: Randomized, placebo-controlled, double-blind study to evaluate the efficacy of 2LHERP® in patients with recurrent genital herpes infections.
    Medical condition: Patients presenting recurrent genital herpes infections (4 or more episodes within the 12-months’ period prior to their study entry).
    Disease: Version SOC Term Classification Code Term Level
    20.0 10021881 - Infections and infestations 10019972 Herpes viral infections HLT
    21.1 10021881 - Infections and infestations 10019948 Herpes simplex PT
    20.1 10021881 - Infections and infestations 10018150 Genital herpes PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: BE (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2017-004116-19 Sponsor Protocol Number: APGELP Start Date*: 2019-04-08
    Sponsor Name:Oslo University Hospital
    Full Title: The AP-GELP Study: A randomized, placebo-controlled clinical trial on the effects of phosphodiesterase 4-inhibitor apremilast in female genital erosive lichen planus
    Medical condition: Genital erosive lichen planus
    Disease:
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: NO (Completed)
    Trial results: (No results available)
    EudraCT Number: 2005-001705-26 Sponsor Protocol Number: CYD-GER-0401 Start Date*: 2005-09-21
    Sponsor Name:Spirig Pharma AG
    Full Title: Efficacy and safety of topically applied cyclodextrin gel (Spirig Pharma) in the treatment of recurrent genital herpes simplex virus infections: a randomised, double-blind, placebo-controlled, mult...
    Medical condition: Genito-anal herpes simplex infections
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2014-002108-25 Sponsor Protocol Number: CC-10004-BCT-002 Start Date*: 2015-06-17
    Sponsor Name:Amgen Inc.
    Full Title: A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP STUDY, FOLLOWED BY AN ACTIVE-TREATMENT PHASE TO EVALUATE THE EFFICACY AND SAFETY OF APREMILAST (CC-10004) IN THE...
    Medical condition: SUBJECTS WITH ACTIVE BEHÇET’S DISEASE
    Disease: Version SOC Term Classification Code Term Level
    21.1 100000004866 10004212 Behcet's disease LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed) IT (Completed) GR (Completed)
    Trial results: View results
    EudraCT Number: 2010-021556-25 Sponsor Protocol Number: IBSA 01-2010 Start Date*: 2011-02-24
    Sponsor Name:IBSA
    Full Title: Phase III, randomized, open-label, multicenter evaluation of efficacy and tolerability `of Ialuril (sodium hyaluronate-chondroitin sulfate) vs. dimethyl sulfoxide (DMSO) in women with interstitial ...
    Medical condition: Interstitial Cystitis
    Disease: Version SOC Term Classification Code Term Level
    9.1 10018188 HLGT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: IT (Completed)
    Trial results: View results
    EudraCT Number: 2018-003675-35 Sponsor Protocol Number: WV2018 Start Date*: 2018-11-01
    Sponsor Name:Karolinska Institutet
    Full Title: Efficacy of Very Early Medical Abortion – a randomized controlled non-inferiority trial
    Medical condition: Unwanted pregnancy
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: SE (Completed) FI (Completed) AT (Completed) DK (Completed)
    Trial results: View results
    EudraCT Number: 2015-002190-37 Sponsor Protocol Number: P140302 Start Date*: 2015-10-30
    Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
    Full Title: A Phase 2 Open-Label Study to Evaluate the Efficacy and Safety of Ustekinumab, a Human Monoclonal Anti-IL-12/IL-23 Antibody, in patients with Behçet disease : STELABEC
    Medical condition: Behçet disease STELABEC-1: patients with oral ulcers STELABEC-2 : patients with active posterior uveitis or panuveitis
    Disease: Version SOC Term Classification Code Term Level
    18.1 100000004866 10004212 Behcet's disease LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: FR (Completed)
    Trial results: (No results available)
    EudraCT Number: 2019-002787-27 Sponsor Protocol Number: 20190530 Start Date*: 2021-03-15
    Sponsor Name:Amgen Inc.
    Full Title: A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study, Followed by an Active Treatment Phase to Evaluate the Efficacy and Safety of Apremilast in Children From ...
    Medical condition: Subjects with active Behçet’s Disease
    Disease: Version SOC Term Classification Code Term Level
    21.1 100000004866 10004212 Behcet's disease LLT
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: FR (Trial now transitioned) NL (Ongoing) GR (Trial now transitioned) IT (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2020-004630-38 Sponsor Protocol Number: HydroceleAlkScler Start Date*: 2021-05-20
    Sponsor Name:Region Jämtland/Härjedalen
    Full Title: Sclerotherapy for hydro and spermatoceles with 99.5% Ethanol, an open clinical multicenter dose escalation study, phase 2
    Medical condition: Hydrocele and Spermatocele
    Disease: Version SOC Term Classification Code Term Level
    20.0 10010331 - Congenital, familial and genetic disorders 10020488 Hydrocele PT
    20.0 10038604 - Reproductive system and breast disorders 10041490 Spermatocele PT
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: SE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2019-001443-52 Sponsor Protocol Number: LLB-2019-02 Start Date*: 2019-11-13
    Sponsor Name:LABO'LIFE Belgium sprl
    Full Title: Randomized study to evaluate 2LVERU® JUNIOR and 2LVERU® efficacy on the treatment of warts. Protocol EVAsION
    Medical condition: Non genital warts infection
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004864 10035150 Planar warts LLT
    20.0 100000004864 10035158 Plantar warts LLT
    20.0 100000004864 10047828 Warts LLT
    21.1 100000004864 10010115 Common warts LLT
    Population Age: Children, Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: BE (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2021-002217-34 Sponsor Protocol Number: FITO-01/21 Start Date*: 2022-07-26
    Sponsor Name:AZIENDA OSPEDALIERO-UNIVERSITARIA CAREGGI
    Full Title: Tuscany project to investigate on efficacy and safety of Cannabis phytotherapic preparations for the treatment of Aromatase iNhibitor-induced chronic resistaNt pAin in Breast cancer patIents: a pro...
    Medical condition: Aromatase iNhibitor-induced chronic resistaNt pAin in Breast cancer patIents
    Disease: Version SOC Term Classification Code Term Level
    20.0 10029205 - Nervous system disorders 10029205 Nervous system disorders SOC
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: IT (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2022-000712-59 Sponsor Protocol Number: APHP200073 Start Date*: 2023-03-14
    Sponsor Name:Assistance Publique - Hôpitaux Paris (Direction de la Recherche Clinique et de l’Innovation)
    Full Title: Severe erythema multiforme: A randomized controlled trial comparing a short systemic corticosteroids regimen to placebo in the acute established phase
    Medical condition: Erythema multiforme (EM) in its severe form managed at the hospital
    Disease: Version SOC Term Classification Code Term Level
    20.0 10040785 - Skin and subcutaneous tissue disorders 10015218 Erythema multiforme PT
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2007-001602-24 Sponsor Protocol Number: Th.B-1(2007):BTX(CP/CPPS) Start Date*: Information not available in EudraCT
    Sponsor Name:Department of Urology and Pediatric Urology - Justus-Liebig-University Giessen
    Full Title: Intraprostatic injection of Botulinumtoxin type A in patients with chronic prostatitis / chronic pelvic pain syndrome (CP/CPPS)
    Medical condition: chronic prostatitis / chronic pelvic pain syndrom
    Disease: Version SOC Term Classification Code Term Level
    9.1 10021965 Inflammation pelvic LLT
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2010-023254-36 Sponsor Protocol Number: GUMPID002 Start Date*: 2011-06-22
    Sponsor Name:Brighton and Sussex University Hospitals NHS Trust
    Full Title: Is a short course of azithromycin effective in the treatment of mild to moderate pelvic inflammatory disease (PID)?
    Medical condition: Pelvic Inflammatory Disease (PID)
    Disease: Version SOC Term Classification Code Term Level
    14.1 10021881 - Infections and infestations 10034254 Pelvic inflammatory disease PT
    Population Age: Adolescents, Under 18, Adults Gender: Female
    Trial protocol: GB (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2016-003952-63 Sponsor Protocol Number: LIQUENIA Start Date*: 2017-07-07
    Sponsor Name:Instituto de Investigación Sanitaria La Fe
    Full Title: Pilot study of vulval lichen sclerosus treatment by adipose tissue associated with autologous platelet-rich plasma
    Medical condition: Vulval lichen sclerosus
    Disease: Version SOC Term Classification Code Term Level
    19.1 100000004858 10047761 Vulval lichen sclerosus et atrophicus LLT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: ES (Completed)
    Trial results: View results
    EudraCT Number: 2020-002945-41 Sponsor Protocol Number: 78464317 Start Date*: 2020-09-24
    Sponsor Name:Lone Nikolajsen
    Full Title: The use of intraoperative methadone in children undergoing open urological surgery
    Medical condition: Postoperative pain in children undergoing open urological surgery
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004865 10031063 Orchiopexy LLT
    20.0 10010331 - Congenital, familial and genetic disorders 10011498 Cryptorchism PT
    20.0 100000004856 10022017 Inguinal hernias HLT
    20.0 10010331 - Congenital, familial and genetic disorders 10020488 Hydrocele PT
    Population Age: Infants and toddlers, Children, Under 18 Gender: Male
    Trial protocol: DK (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2014-004581-16 Sponsor Protocol Number: V501-030 Start Date*: 2015-04-02
    Sponsor Name:Merck Sharp & Dohme (China) Ltd.
    Full Title: An Immunogenicity and Safety Study of GARDASIL™ in Chinese Female Subjects Aged 9 to 45 Years and Male Subjects Aged 9 to 15 Years
    Medical condition: Prevention of HPV types 6, 11, 16 and 18 related cervical cancer, vulvar, vaginal pre-cancers, low-grade, pre-cancerous lesions, and genital warts in Chinese female subjects aged 9 to 45 years and ...
    Disease:
    Population Age: Children, Adolescents, Under 18, Adults Gender: Male, Female
    Trial protocol: Outside EU/EEA
    Trial results: View results
    EudraCT Number: 2007-003343-74 Sponsor Protocol Number: PDS234 Start Date*: 2007-10-30
    Sponsor Name:Academic Medical Center
    Full Title: A methodological investigation to test acute changes in female sexual desire in healthy volunteersand pre- and postmenopausal women diagnosed with hypoactive sexual desiredisordersusing explicit me...
    Medical condition: hypoactive sexual desire disorder in women (HSDD)
    Disease: Version SOC Term Classification Code Term Level
    9.1 10062641 Female sexual arousal disorder LLT
    Population Age: Adults Gender: Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2020-004703-14 Sponsor Protocol Number: ACT16404 Start Date*: 2021-05-12
    Sponsor Name:Sanofi-Aventis Recherche & Développement
    Full Title: A randomized, double-blind, placebo controlled, proof of concept study assessing the efficacy and safety of the RIPK1-inhibitor SAR443122 in patients with moderate to severe subacute or discoid/chr...
    Medical condition: Cutaneous Lupus Erythematosus
    Disease: Version SOC Term Classification Code Term Level
    21.1 10040785 - Skin and subcutaneous tissue disorders 10056509 Cutaneous lupus erythematosus PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: HU (Completed) PL (Completed) IT (Completed)
    Trial results: View results
    EudraCT Number: 2013-003107-19 Sponsor Protocol Number: 13-0288 Start Date*: 2014-04-28
    Sponsor Name:University of Birmingham [...]
    1. University of Birmingham
    2. Sandwell and West Birmingham Hospitals NHS Trust
    Full Title: Phase II clinical trial investigating the use of epigallocatechin-3-gallate (Veregen) in the treatment of vulval intraepithelial neoplasia
    Medical condition: Vulval intraepithelial neoplasia (VIN)
    Disease: Version SOC Term Classification Code Term Level
    16.1 100000004864 10057313 Vulval intraepithelial neoplasia grade III LLT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: GB (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Tue Oct 28 19:09:32 CET 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA